Cargando…

Proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia

BACKGROUND: Splenectomy is the most effective treatment for patients with primary immune thrombocytopenia (ITP) who fail to respond to steroid therapy. Thus far, there is no effective means to predict the long-term haematological response of the procedure. The purpose of this study was to identify s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Chao-Xu, Ji, Zhuang-Qi, Zhang, Long-Juan, Wen, Qiong, Chen, Liu-Hua, Yu, Jun-Feng, Zheng, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506455/
https://www.ncbi.nlm.nih.gov/pubmed/23039040
http://dx.doi.org/10.1186/1479-5876-10-208
_version_ 1782250905774587904
author Zheng, Chao-Xu
Ji, Zhuang-Qi
Zhang, Long-Juan
Wen, Qiong
Chen, Liu-Hua
Yu, Jun-Feng
Zheng, Dong
author_facet Zheng, Chao-Xu
Ji, Zhuang-Qi
Zhang, Long-Juan
Wen, Qiong
Chen, Liu-Hua
Yu, Jun-Feng
Zheng, Dong
author_sort Zheng, Chao-Xu
collection PubMed
description BACKGROUND: Splenectomy is the most effective treatment for patients with primary immune thrombocytopenia (ITP) who fail to respond to steroid therapy. Thus far, there is no effective means to predict the long-term haematological response of the procedure. The purpose of this study was to identify serum biomarkers as predictors of long-term response based on a proteomics approach. METHODS: The serum samples of ITP patients were collected before splenectomy and seven days after surgery. After depletion of the abundant serum proteins, pooled preoperative serum samples from four responders to splenectomy, four nonresponders and four healthy controls were subjected to two-dimensional gel electrophoresis (2-DE). Nine protein spots with at least a five-fold alteration in expression between responders and nonresponders were all identified as haptoglobin (Hp) by matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometer (MS) analysis. The validation of serum Hp expression was performed using enzyme-linked immunosorbent assays (ELISA) in thirty-seven responders, thirteen nonresponders and twenty-one healthy controls. RESULTS: The preoperative serum levels of Hp in the nonresponders (925.9 ± 293.5 μg/ml) were significantly lower than those in the responders (1417.4 ± 315.0 μg/ml, p <0.001) and the healthy controls (1409.1 ± 354.2 μg/ml, p <0.001), while there was no significant difference between the latter two groups. The postoperative serum levels of Hp in responders and nonresponders were (1414.1 ± 225.0 μg/ml) and (952.9 ± 202.4 μg/ml), respectively. There were no significant differences between the serum Hp levels before and after surgery in both responders and nonresponders (p>0.05). The preoperative serum levels of Hp did not significantly correlate with preoperative platelet count of the same blood samples (r = 0.244, p = 0.087), while it positively correlated with postoperative peak platelet count (r = 0.622, p < 0.001). The optimal cutoff value of preoperative serum Hp levels (1173.80 μg/ml) derived from the receiver operating characteristic (ROC) curve led to 78.4% sensitivity and 84.6% specificity. CONCLUSIONS: These results suggest that serum Hp levels may serve as a favourable predictor for the long-term response to splenectomy in ITP and may help to understand the pathophysiological differences between responders and nonresponders.
format Online
Article
Text
id pubmed-3506455
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35064552012-11-27 Proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia Zheng, Chao-Xu Ji, Zhuang-Qi Zhang, Long-Juan Wen, Qiong Chen, Liu-Hua Yu, Jun-Feng Zheng, Dong J Transl Med Research BACKGROUND: Splenectomy is the most effective treatment for patients with primary immune thrombocytopenia (ITP) who fail to respond to steroid therapy. Thus far, there is no effective means to predict the long-term haematological response of the procedure. The purpose of this study was to identify serum biomarkers as predictors of long-term response based on a proteomics approach. METHODS: The serum samples of ITP patients were collected before splenectomy and seven days after surgery. After depletion of the abundant serum proteins, pooled preoperative serum samples from four responders to splenectomy, four nonresponders and four healthy controls were subjected to two-dimensional gel electrophoresis (2-DE). Nine protein spots with at least a five-fold alteration in expression between responders and nonresponders were all identified as haptoglobin (Hp) by matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometer (MS) analysis. The validation of serum Hp expression was performed using enzyme-linked immunosorbent assays (ELISA) in thirty-seven responders, thirteen nonresponders and twenty-one healthy controls. RESULTS: The preoperative serum levels of Hp in the nonresponders (925.9 ± 293.5 μg/ml) were significantly lower than those in the responders (1417.4 ± 315.0 μg/ml, p <0.001) and the healthy controls (1409.1 ± 354.2 μg/ml, p <0.001), while there was no significant difference between the latter two groups. The postoperative serum levels of Hp in responders and nonresponders were (1414.1 ± 225.0 μg/ml) and (952.9 ± 202.4 μg/ml), respectively. There were no significant differences between the serum Hp levels before and after surgery in both responders and nonresponders (p>0.05). The preoperative serum levels of Hp did not significantly correlate with preoperative platelet count of the same blood samples (r = 0.244, p = 0.087), while it positively correlated with postoperative peak platelet count (r = 0.622, p < 0.001). The optimal cutoff value of preoperative serum Hp levels (1173.80 μg/ml) derived from the receiver operating characteristic (ROC) curve led to 78.4% sensitivity and 84.6% specificity. CONCLUSIONS: These results suggest that serum Hp levels may serve as a favourable predictor for the long-term response to splenectomy in ITP and may help to understand the pathophysiological differences between responders and nonresponders. BioMed Central 2012-10-07 /pmc/articles/PMC3506455/ /pubmed/23039040 http://dx.doi.org/10.1186/1479-5876-10-208 Text en Copyright ©2012 Zheng et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zheng, Chao-Xu
Ji, Zhuang-Qi
Zhang, Long-Juan
Wen, Qiong
Chen, Liu-Hua
Yu, Jun-Feng
Zheng, Dong
Proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia
title Proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia
title_full Proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia
title_fullStr Proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia
title_full_unstemmed Proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia
title_short Proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia
title_sort proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506455/
https://www.ncbi.nlm.nih.gov/pubmed/23039040
http://dx.doi.org/10.1186/1479-5876-10-208
work_keys_str_mv AT zhengchaoxu proteomicsbasedidentificationofhaptoglobinasafavourableserumbiomarkerforpredictinglongtermresponsetosplenectomyinpatientswithprimaryimmunethrombocytopenia
AT jizhuangqi proteomicsbasedidentificationofhaptoglobinasafavourableserumbiomarkerforpredictinglongtermresponsetosplenectomyinpatientswithprimaryimmunethrombocytopenia
AT zhanglongjuan proteomicsbasedidentificationofhaptoglobinasafavourableserumbiomarkerforpredictinglongtermresponsetosplenectomyinpatientswithprimaryimmunethrombocytopenia
AT wenqiong proteomicsbasedidentificationofhaptoglobinasafavourableserumbiomarkerforpredictinglongtermresponsetosplenectomyinpatientswithprimaryimmunethrombocytopenia
AT chenliuhua proteomicsbasedidentificationofhaptoglobinasafavourableserumbiomarkerforpredictinglongtermresponsetosplenectomyinpatientswithprimaryimmunethrombocytopenia
AT yujunfeng proteomicsbasedidentificationofhaptoglobinasafavourableserumbiomarkerforpredictinglongtermresponsetosplenectomyinpatientswithprimaryimmunethrombocytopenia
AT zhengdong proteomicsbasedidentificationofhaptoglobinasafavourableserumbiomarkerforpredictinglongtermresponsetosplenectomyinpatientswithprimaryimmunethrombocytopenia